Atypical 5′ splice sites cause CFTR exon 9 to be vulnerable to skipping

被引:27
作者
Hefferon, TW
Broackes-Carter, FC
Harris, A
Cutting, GR
机构
[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet & Mol Bi, Baltimore, MD USA
[3] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England
基金
美国国家卫生研究院;
关键词
D O I
10.1086/341664
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The molecular basis of the skipping of constitutive exons in many messenger RNAs is not fully understood. A well-studied example is exon 9 of the human cystic fibrosis transmembrane conductance regulator gene (CFTR), in which an abbreviated polypyrimidine tract between the branch point A and the 3 splice site is associated with increased exon skipping and disease. However, many exons, both in CFTR and in other genes and have short polypyrimidine tracts in their 3 splice sites, yet they are not skipped. Inspection of the 5 splice sites immediately up- and downstream of exon 9 revealed deviations from consensus sequence, so we hypothesized that this exon may be inherently vulnerable to skipping. To test this idea, we constructed a CFTR minigene and replicated exon 9 skipping associated with the length of the polypyrimidine tract upstream of exon 9. We then mutated the flanking 5 splice sites and determined the effect on exon skipping. Conversion of the upstream 5 splice site to consensus by replacing a pyrimidine at position +3 with a purine resulted in increased exon skipping. In contrast, conversion of the downstream 5 splice site to consensus by insertion of an adenine at position +4 resulted in a substantial reduction in exon 9 skipping, regardless of whether the upstream 5 splice site was consensus or not. These results suggested that the native downstream 5 splice site plays an important role in CFTR exon 9 skipping, a hypothesis that was supported by data from sheep and mouse genomes. Although CFTR exon 9 in sheep is preceded by a long polypyrimidine tract (Y-14), it skips exon 9 in vivo and has a nonconsensus downstream 5 splice site identical to that in humans. On the other hand, CFTR exon 9 in mice is preceded by a short polypyrimidine tract (Y-5) but is not skipped in vivo. Its downstream 5 splice site differs from that in humans by a 2-nt insertion, which, when introduced into the human CFTR minigene, abolished exon 9 skipping. Taken together, these observations place renewed emphasis on deviations at 5 splice sites in nucleotides other than the invariant GT, particularly when such changes are found in conjunction with other altered splicing sequences, such as a shortened polypyrimidine tract. Thus, careful inspection of entire 5 splice sites may identify constitutive exons that are vulnerable to skipping.
引用
收藏
页码:294 / 303
页数:10
相关论文
共 37 条
[31]   EXPRESSION OF AN ABUNDANT ALTERNATIVELY SPLICED FORM OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE IS NOT ASSOCIATED WITH A CAMP-ACTIVATED CHLORIDE CONDUCTANCE [J].
STRONG, TV ;
WILKINSON, DJ ;
MANSOURA, MK ;
DEVOR, DC ;
HENZE, K ;
YANG, YP ;
WILSON, JM ;
COHN, JA ;
DAWSON, DC ;
FRIZZELL, RA ;
COLLINS, FS .
HUMAN MOLECULAR GENETICS, 1993, 2 (03) :225-230
[32]   MOLECULAR ANALYSIS OF THE OVINE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE [J].
TEBBUTT, SJ ;
WARDLE, CJC ;
HILL, DF ;
HARRIS, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (06) :2293-2297
[33]   Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells [J].
Teng, H ;
Jorissen, M ;
VanPoppel, H ;
Legius, E ;
Cassiman, JJ ;
Cuppens, H .
HUMAN MOLECULAR GENETICS, 1997, 6 (01) :85-90
[34]   Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A→G, 2751+2T→A, 296+1G→C, 1717-9T→C-D565G) and one nonsense mutation (ES22X) in the CFTR gene [J].
Tzetis, M ;
Efthymiadou, A ;
Doudounakis, S ;
Kanavakis, E .
HUMAN GENETICS, 2001, 109 (06) :592-601
[35]   Splice-site mutations in atherosclerosis candidate genes - Relating individual information to phenotype [J].
von Kodolitsch, Y ;
Pyeritz, RE ;
Rogan, PK .
CIRCULATION, 1999, 100 (07) :693-699
[36]  
ZANDBERG H, 1995, NUCLEIC ACIDS RES, V23, P248
[37]  
ZIELENSKI J, 1995, AM J HUM GENET, V57, P958